Schnitzer is also the surgical team leader of the National Disaster Medical
System International Medical Surgical Response Team and was deployed to New
York City on September 11, 2001 and Bam, Iran following a 2003 earthquake.
In addition, Dr. Schnitzer represented the MGH in the Center for the
Integration of Medicine and Innovative Technology, an inter-institutional
consortium that seeks new technology solutions for unmet needs in various
medical disciplines, where he worked alongside Dr. Baim who represented the
Brigham and Women's Hospital until joining Boston Scientific in 2006.
"We are delighted to have Dr. Schnitzer joining our team," said Dr.
Baim. "He is a senior clinician who brings a unique background to bear on
our Clinical Sciences organization, and he will provide invaluable medical
leadership for these critical business areas."
Boston Scientific is a worldwide developer, manufacturer and marketer
of medical devices whose products are used in a broad range of
interventional medical specialties. For more information, please visit:
Cautionary Statement Regarding Forward Looking Statements
This press release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements may be identified by words like "anticipate,"
"expect," "project," "believe," "plan," "estimate," "intend" and similar
words. These forward- looking statements are based on our beliefs,
assumptions and estimates using information available to us at the time and
are not intended to be guarantees of future events or performance. These
forward-looking statements include, among other things, statements
regarding clinical trials, scientific activities, our medical input
process, growth investment and educational publications. If our underlying
assumptions turn out to be incorrect, or if cer
Page: 1 2 3 4 Related biology technology :1
|SOURCE Boston Scientific Corporation|
Copyright©2008 PR Newswire.
All rights reserved
. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses2
. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA3
. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan4
. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference5
. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases6
. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors7
. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University8
. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System9
. Genzyme Begins Major Expansion of Boston Manufacturing Facility10
. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute11
. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results